NFSG
Newbridge Financial Services Group’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Sell |
16,760
-457
| -3% | -$49.1K | 0.29% | 71 |
|
|
2025
Q1 | $1.74M | Sell |
17,217
-130
| -0.7% | -$13.1K | 0.42% | 54 |
|
|
2024
Q4 | $1.55M | Buy |
17,347
+1,975
| +13% | +$176K | 0.4% | 54 |
|
|
2024
Q3 | $1.29M | Buy |
15,372
+6,240
| +68% | +$523K | 0.45% | 53 |
|
|
2024
Q2 | $703K | Buy |
9,132
+8,717
| +2,100% | +$671K | 0.26% | 76 |
|
|
2024
Q1 | $28.4K | Buy |
+415
| New | +$28.4K | 0.01% | 529 |
|
|
2023
Q4 | – | Sell |
-170
| Closed | -$8.98K | – | 1188 |
|
|
2023
Q3 | $8.98K | Hold |
170
| – | – | ﹤0.01% | 846 |
|
|
2023
Q2 | $9.2K | Hold |
170
| – | – | ﹤0.01% | 901 |
|
|
2023
Q1 | $8.51K | Hold |
170
| – | – | ﹤0.01% | 939 |
|
|
2022
Q4 | $7.87K | Hold |
170
| – | – | ﹤0.01% | 964 |
|
|
2022
Q3 | $7K | Sell |
170
-249
| -59% | -$10.3K | ﹤0.01% | 963 |
|
|
2022
Q2 | $16K | Sell |
419
-1,245
| -75% | -$47.5K | 0.01% | 718 |
|
|
2022
Q1 | $74K | Hold |
1,664
| – | – | 0.04% | 369 |
|
|
2021
Q4 | $71K | Hold |
1,664
| – | – | 0.03% | 374 |
|
|
2021
Q3 | $72K | Sell |
1,664
-436
| -21% | -$18.9K | 0.05% | 323 |
|
|
2021
Q2 | $90K | Buy |
2,100
+422
| +25% | +$18.1K | 0.06% | 300 |
|
|
2021
Q1 | $65K | Sell |
1,678
-688
| -29% | -$26.7K | 0.05% | 337 |
|
|
2020
Q4 | $85K | Sell |
2,366
-2,177
| -48% | -$78.2K | 0.07% | 240 |
|
|
2020
Q3 | $174K | Buy |
+4,543
| New | +$174K | 0.17% | 124 |
|